Addendum to the note for guidance on antiarrhythmics on atrial fibrillation and atrial flutter

  • Email
  • Help
Current effective version

Adopted guideline

Reference numberCHMP/EWP/213056/2010
Effective from01/02/2011
KeywordsAtrial fibrillation, rhythm control, rate control, cardioversion
DescriptionThis document is an addendum to the note for guidance on antiarrhythmics. It provides guidance for the evaluation of new medicinal products or drugs used in the antiarrhythmic treatment of atrial fibrillation.

Document history

First version

Current version

Adopted guideline


Draft guideline


Concept paper

In operation: 01/12/2011–present


Published: 24/07/2008


Published: 21/09/2006

Related content

How helpful is this page?

Average rating:

 Based on 25 ratings

Add your rating:

See all ratings
5 ratings
5 ratings
5 ratings
5 ratings
5 ratings

Tell us more